C07D 239/14
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
C07D239/14 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said) appears on 114 US grants and 78 published applications in this corpus.
Search patents in C07D- Granted patents
- 114
- Published applications
- 78
- Assignees
- 76
- Inventors
- 324
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 6 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 4 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 2 |
| 2002 | 5 | 6 |
| 2003 | 3 | 3 |
| 2004 | 8 | 5 |
| 2005 | 2 | 4 |
| 2006 | 1 | 4 |
| 2007 | 3 | 1 |
| 2008 | 0 | 5 |
| 2009 | 1 | 2 |
| 2010 | 2 | 3 |
| 2011 | 1 | 1 |
| 2012 | 3 | 5 |
| 2013 | 3 | 3 |
| 2014 | 7 | 6 |
| 2015 | 3 | 5 |
| 2016 | 3 | 2 |
| 2017 | 4 | 2 |
| 2018 | 2 | 4 |
| 2019 | 4 | 4 |
| 2020 | 2 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 4 |
| 2024 | 0 | 3 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Compound and composition as PDGF receptor kinase inhibitor30 Dec 2025US 12,509,424 B2Nippon Shinyaku Co., Ltd.
- 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof29 Aug 2023US 11,739,100 B2Sanofi
- Alpha-5 beta-1 inhibitors20 Dec 2022US 11,530,180 B2Shanghai Chempartner Co., Ltd
- 6-membered uracil isosteres16 Nov 2021US 11,174,271 B2CV6 Therapeutics (NI) Limited
- Inhibitors of creatine transport and uses thereof21 Jul 2020US 10,717,704 B2Rgenix, Inc.
- Heterocyclic derivatives as camkk2 inhibitors25 Jul 2024US 2024/0246969 A1Bristol-Myers Squibb Company
- Novel compound as protein kinase inhibitors9 May 2024US 2024/0150325 A1LG Chem.Ltd.
- Substituted pyrimidine derivatives as nicotinic acetylcholinesterase receptor alpha 6 modulator22 Feb 2024US 2024/0059677 A1Cerevance, Inc.
- Integrin targeting ligands and uses thereof21 Dec 2023US 2023/0407313 A1Arrowhead Pharmaceuticals, Inc.
- Herbicidal compounds and methods of use thereof19 Oct 2023US 2023/0331685 A1AG Plenus Ltd
Most cited
By later US patents
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998
- Muscarinic agonist compounds69US 5,618,818 AThe University of Toledo · 1997
- Biaryl compounds as serine protease inhibitors57US 6,699,994 B1BioCryst Pharmaceuticals, Inc. · 2004
- Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption41US 5,741,796 AMerck & Co., Inc. · 1998
- Peptides derivatives40US 5,602,253 AAktiebolaget Astra · 1997